Yahoo
NasdaqGM - Nasdaq Real Time Price USD

Neuphoria Therapeutics Inc. (NEUP)

3.0200 -0.0300 (-0.98%)
As of 2:38:48 PM EST. Market Open.

Earnings Trends

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY26
Revenue 1.65M
Earnings -6.9M
Profit Margin -417.70%

Q1

FY26

Q2

FY26

Q3

FY26

Q4

FY26

-15M
-10M
-5M
0
-400.0%
-300.0%
-200.0%
-100.0%
0.0%

Revenue Estimate

Currency in AUD
Current Qtr. (Sep 2026)
Next Qtr. (Dec 2026)
Current Year (2027)
Next Year (2028)
No. of Analysts
1 1 1 1
Avg. Estimate
-- -- -- --
Low Estimate
-- -- -- --
High Estimate
-- -- -- --
Year Ago Sales
-- -- 1.65M --
Sales Growth (year/est)
0.00% 0.00% -100.00% 0.00%

Earnings Estimate

GAAP
Normalized
Currency in USD
Current Qtr. (Sep 2026)
Next Qtr. (Dec 2026)
Current Year (2027)
Next Year (2028)
No. of Analysts
-- -- 1 1
Avg. Estimate
-- -- -2.43 -2.46
Low Estimate
-- -- -2.43 -2.46
High Estimate
-- -- -2.43 -2.46
Year Ago EPS
-- -- -1.85 -2.43

Earnings History

GAAP
Normalized
Currency in USD
9/30/2025
12/31/2025
3/31/2026
6/30/2026
EPS Est.
-1.31 -0.56 -0.56 -0.56
EPS Actual
-4.41 0.41 -0.09 0.26
Difference
-3.1 0.97 0.47 0.82
Surprise %
-236.64% 173.21% 83.93% 145.91%

EPS Trend

GAAP
Normalized
Currency in USD
Current Qtr. (Sep 2026)
Next Qtr. (Dec 2026)
Current Year (2027)
Next Year (2028)
Current Estimate
-- -- -2.43 -2.46
7 Days Ago
-- -- -2.43 -2.46
30 Days Ago
-- -- -2.43 -2.46
60 Days Ago
-- -- -2.43 -2.46
90 Days Ago
-- -- -2.43 -2.46

EPS Revisions

GAAP
Normalized
Currency in USD
Current Qtr. (Sep 2026)
Next Qtr. (Dec 2026)
Current Year (2027)
Next Year (2028)
Up Last 7 Days
-- -- -- --
Up Last 30 Days
-- -- -- --
Down Last 7 Days
-- -- 1 --
Down Last 30 Days
-- -- 1 --

Growth Estimates

Symbol Current Qtr. Next Qtr. Current Year Next Year
NEUP
-- -- -31.15% -1.23%
S&P 500
26.99% 26.80% 32.87% 16.85%

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: